欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/3406/001
药品名称
Rosuvastatin Mylan
活性成分
Rosuvastatin calcium 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Mylan AB, PO 23033, 104 35, Stockholm, Sverige (L-259378)
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Cyprus (CY)
Rosuvastatin Mylan 5mg film-coated tablets
Sweden (SE)
Rosuvastatin Mylan
Croatia (HR)
Ireland (IE)
Belgium (BE)
Rosuvastatine Viatris 5 mg filmomhulde tabletten
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
ROSUVASTATIN/GENERICS
许可日期
2011/07/19
最近更新日期
2024/11/16
药物ATC编码
C10AA07 rosuvastatin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
SPC_LAB_PIL_Rosuvastatin Mylan_SK_H_0133_01_04_E_01
Date of last change:2024/09/06
Final Product Information
|
common_combined_dk3406_v039_clean
Date of last change:2024/09/06
PubAR
|
PAR_Rosuvastatin Mylan
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase